Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
1 kopie van APOE3 Christchurch-variant vertraagt autosomaal dominante ziekte van Alzheimer
aug 2024 | Dementie